Kodiak Sciences Inc. logo

Kodiak Sciences Inc.

NASDAQ:KOD

Overview | Financials
Company Name Kodiak Sciences Inc.
Symbol KOD
Currency USD
Price 2.31
Market Cap 121,539,957
Dividend Yield 0%
52-week-range 1.37 - 7.77
Industry Biotechnology
Sector Healthcare
CEO Dr. Victor Perlroth M.D.
Website https://kodiak.com

An error occurred while fetching data.

About Kodiak Sciences Inc.

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment

Related Stocks

Arcellx, Inc. logo

Arcellx, Inc.

ACLX

71.25 USD

Regencell Bioscience Holdings Limited logo

Regencell Bioscience Holdings Limited

RGC

6.69 USD

Belite Bio, Inc logo

Belite Bio, Inc

BLTE

48.2 USD

Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc.

OTLK

7.95 USD

Arbutus Biopharma Corporation logo

Arbutus Biopharma Corporation

ABUS

4.55 USD

Mind Medicine (MindMed) Inc. logo

Mind Medicine (MindMed) Inc.

MNMD

5.945 USD

Esperion Therapeutics, Inc. logo

Esperion Therapeutics, Inc.

ESPR

1.65 USD

Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc.

TYRA

20.59 USD

Financials

Numbers are in millions USD

Numbers are in millions USD